The evidence provided by this study supported the instance that the PCDHB17P/miR-145-3p/MELK/NF-κB axis is implicated in the metastasis and angiogenesis of breast cancer and may be considered as a potential target for the breast cancer therapies in the future. This evidence concerns the gene MELK and breast carcinoma.